CompletedNot Applicable

Wireless Handheld 8-lead ECG Device Performance in Heart Patients (Rapid Rhythm)

United Kingdom271 participantsStarted 2017-01-24

Plain-language summary

This study is designed to compare the performance of both 6 and 10 electrode ECGs from the handheld device with the conventional 12 lead ECG. As well as comparing the detection of atrial fibrillation, the study will also compare the detection of other heart problems and of normal heart rhythm.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Patient attending an adult cardiology or anti-coagulation clinic appointment, at clinics at Central Manchester University Hospitals NHS Foundation Trust (including the Manchester Heart Centre).
✓. Patients on cardiac wards 3 and 4.
✓. Aged 18 years or above.
✓. Male or Female.

Exclusion criteria

✕. Aged less than 18 years.
✕. Unable to give informed consent.
✕. Does not wish to participate in the study.
✕. Any patients with visible breaks to the skin, rashes or inflammation in the chest area on the day of the test
✕. Bedridden or otherwise unable to transfer between chair and bed for both seated and supine measurements

What they're measuring

Capabilities of an 8 lead ECG system (Rapid Rhythm) - normal ECGs

Timeframe: 18 months

Capabilities of an 8 lead ECG system (Rapid Rhythm) - abnormal ECGs

Timeframe: 18 months

Trial details

NCT IDNCT03501836

SponsorManchester University NHS Foundation Trust

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2019-06-30

View on ClinicalTrials.gov More Atrial Fibrillation trials